[271]
General Pathology 8 January 26, Wednesday, 2005 Masashi Fukayama ...
[47,1 KB]
From [ocw.u-tokyo.ac.jp] Last viewed: 07.09.2006
General Pathology 8 January 26, Wednesday, 2005 Masashi Fukayama
Basics of tumor pathology
I. Molecular pathology of tumors
A. Biology of tumors
classical definition: lesions generated by “ autonomic ” proliferation of a cell, the
proliferation continues after the removal of a stimulus
basic nature of tumors : tumors are monoclonal.
biological features of tumor cells: transplantable / infinite proliferation ability,
immortalization / loss of contact inhibition / loss of anchorage dependency
/deterioration of cellular adhesiveness / cell membrane alteration / tumor antigen
(carcinoembryonic antigen, carbohydrate tumor antigen)
B. Multistage carcinogenesis
C. Oncogene and tumor suppressor gene: the history of their discovery
1) carcinogenesis and gene variation, gene defects: radiation, carcinogen / cancer
virus ( Rous sarcoma virus)
2) oncogene, unified theory of ...
[272]
Cancer Detection Guide
[439,3 KB]
From [www.nfcr.org] Last viewed: 07.09.2006
Cancer Detection Guide
1. As a minimum, includes history, physical exam, blood/urine laboratory tests
and chest x-ray as determined by your physician.
2. Annual screening should be offered to individuals beginning at age 35 who
belong to high-risk groups, defined as women with or at risk for hereditary
nonpolyposis colorectal cancer (HNPCC). Women at average risk should be
informed of the early symptoms of endometrial cancer and report any
unexpected bleeding or spotting to their physicians.
3. Proctosigmoidoscopy – colon/rectal exam
4. Those in high-risk categories should begin at age 45.
National Foundation for Cancer Research, 4600 East West Highway, Suite 525, Bethesda, MD 20814, www.NFCR.org
I-5331-1204
AGE
FREQUENCY
FEMALES
MALES
18-20
One time
Complete Health Exam
1
Complete Health ...
[273]
Advocating for cervical cancer prevention
[107,5 KB]
From [www.womenshealth-elsevier.com] Last viewed: 07.09.2006
ARTICLE
Advocating for cervical cancer prevention
J. Sherris
a,
T , I. Agurto
b
, S. Arrossi
c
, I. Dzuba
d
, L. Gaffikin
e
, C. Herdman
a
,
K. Limpaphayom
f
, S. Luciani
b
a
PATH, 1455 NW Leary Way, Seattle, WA 98107, USA
b
PAHO (Pan American Health Organization), Washington, DC, USA
c
International Agency for Research on Cancer (IARC), Lyon, France
d
EngenderHealth, New York, NY, USA
e
JHPIEGO, Baltimore, MD, USA
f
Department of Obstetrics/Gynaecology, Faculty of Medicine, Chulalongkhorn University,
Bangkok, Thailand
Abstract
Cervical cancer is asignificant health problem among women in developing
countries. Contributing to the cervical ...
[274]
Preventing cervical cancer in low-resource settings: Building a ...
[53,0 KB]
From [www.womenshealth-elsevier.com] Last viewed: 07.09.2006
EDITORIAL
Preventing cervical cancer in low-resource
settings: Building a case for the possible
Historical progress in the reduction of morbidity
and mortality from cervical cancer has been
attributed to systematic screening programs in
wealthy countries—an option that has long seemed
out of reach for poorer countries. Recent develop-
ments suggest, however, that there is new hope for
bringing cervical cancer under control, even in
countries with limited financial and infrastructural
resources.
References to cervical cancer appear as early as
the fifth century BC, in Greek and Hindu texts, but
more complete descriptions of the disease and its
treatment first appear in various medical texts in
the 19th century [1] . In 1900, Cullen introduced the
concept that precursor lesions were harbingers of
cancer of the cervix [2] . Over the course of the
next ...
[275]
Preventing cervical cancer in low-resource settings: How far have ...
[73,3 KB]
From [www.womenshealth-elsevier.com] Last viewed: 07.09.2006
ARTICLE
Preventing cervical cancer in low-resource
settings: How far have we come and what
does the future hold?
V.D. Tsu
a,
T , A.E. Pollack
b
a
Program for Appropriate Technology in Health (PATH), 1455 NW Leary Way, Seattle,
WA 98107-5136, USA
b
EngenderHealth, New York, NY, USA
Abstract
The Alliance for Cervical Cancer Prevention (ACCP) came together in
1999 to answer key research questions and to advocate for greater global and
national interest in reducing the heavy burden of morbidity and mortality caused by
this preventable disease. Visual inspection with acetic acid (VIA), visual inspection
with Lugol’s iodine (VILI), and human papillomavirus (HPV) tests have been shown to
be viable alternatives to traditional cytology. ACCP experience confirmed that
cryotherapy is a safe and effective method that is acceptable ...
[276]
Delivering cervical cancer prevention services in low-resource ...
[116,6 KB]
From [www.womenshealth-elsevier.com] Last viewed: 07.09.2006
ARTICLE
Delivering cervical cancer prevention services in
low-resource settings
J. Bradley
a,
T , M. Barone
a
, C. Mahé
b
, R. Lewis
c
, S. Luciani
d
a
EngenderHealth, 440 Ninth Avenue, New York, NY 10001, USA
b
International Agency for Research on Cancer (IARC), Lyon, France
c
JHPIEGO, Baltimore, MD, USA
d
Pan American Health Organization (PAHO), Washington, DC, USA
Abstract
The goals of any cervical cancer prevention program should be threefold:
to achieve high coverage of the population at risk, to screen women with an accurate
test as part of high-quality services, and to ensure that women with positive test
results are properly managed. This article focuses on the experiences of the Alliance
for Cervical Cancer Prevention ...
[277]
Involving the community in cervical cancer prevention programs
[98,3 KB]
From [www.womenshealth-elsevier.com] Last viewed: 07.09.2006
ARTICLE
Involving the community in cervical cancer
prevention programs
I. Agurto
a,
*
, S. Arrossi
b
, S. White
a
, P. Coffey
c
, I. Dzuba
d
,
A. Bingham
c
, J. Bradley
d
, R. Lewis
e
a
Pan American Health Organization (PAHO), 525 23rd Street, NW, Washington, DC 20037, USA
b
International Agency for Research in Cancer (IARC), Lyon, France
c
PATH, Seattle, WA, USA
d
EngenderHealth, New York, NY, USA
e
JHPIEGO, Baltimore, MD, USA
Abstract Underutilization of cervical cancer prevention services by women in the
high-risk age group of 30—60 years can be attributed to health service factors (such
as poor availability, poor accessibility, and poor quality ...
[278]
Training for cervical cancer prevention programs in low-resource ...
[94,3 KB]
From [www.womenshealth-elsevier.com] Last viewed: 07.09.2006
ARTICLE
Training for cervical cancer prevention programs in
low-resource settings: Focus on visual inspection
with acetic acid and cryotherapy
P.D. Blumenthal
a,b,
T , M. Lauterbach
a
, J.W. Sellors
c
, R. Sankaranarayanan
d
a
JHPIEGO, Baltimore, 1615 Thames Street, Baltimore, MD 21231-3492, USA
b
Department of Gynecology and Obstetrics, Johns Hopkins University, Baltimore, MD, USA
c
PATH, Seattle, WA, USA
d
International Agency for Research on Cancer (IARC), Lyon, France
Abstract
The modern approach to cervical cancer prevention, characterized by
use of cytology and multiple visits for diagnosis and treatment, has frequently
proven challenging and unworkable in low-resource settings. Because of this, the
Alliance for Cervical Cancer Prevention (ACCP) ...
[279]
Automated cancer diagnosis based on histopathological images: a ...
[804,6 KB]
From [www.cs.rpi.edu] Last viewed: 07.09.2006
TECHNICAL REPORT, RENSSELAER POLYTECHNIC INSTITUTE, DEPARTMENT OF COMPUTER SCIENCE, TR-05-09.
1
Automated cancer diagnosis based on
histopathological images: a systematic survey
Cigdem Demir and Bulent Yener
Abstract
In traditional cancer diagnosis, pathologists examine biopsies to make diagnostic assessments largely based on cell
morphology and tissue distribution. However, this is subjective and often leads to considerable variability. On the other
hand, computational diagnostic tools enable objective judgments by making use of quantitative measures. This paper
presents a systematic survey of the computational steps in automated cancer diagnosis based on histopathology. These
computational steps are: 1.) image preprocessing to determine the focal areas, 2.) feature extraction to quantify the
properties of these focal areas, and 3.) classifying the focal areas as malignant or not or identifying ...
[280]
Canadian Cancer Statistics 2005
[1024,5 KB]
From [www.cancer.ca] Last viewed: 07.09.2006
For more information about breast health or breast cancer , call the Susan G. Komen
Breast Cancer Foundation’s Toll-Free Helpline at 1.800 I’M AWARE
®
(1.800.462.9273)
or visit the Web site at www.komen.org.
genetics & breast cancer
Who has mutations in BRCA1
and BRCA2?
The likelihood that you have mutations in the
BRCA1 or BRCA2 genes is greater if one or more
of the following statements is true for you:
you are younger (below age 50)
your mother, sister or daughter has had breast
cancer before age 50 or ovarian cancer at any age
a woman in your family has had both breast
cancer and ovarian cancer
a woman in your family has had breast cancer
in both breasts
your family is of Ashkenazi Jewish descent
there is male breast cancer in your family
Remember, most women who get breast cancer do
not have an inherited gene mutation in ...
[281]
Diet and Cancer Prevention
[42,9 KB]
From [www.nutrition.org.uk] Last viewed: 07.09.2006
Diet and Cancer Prevention
Key points
? Cancer occurs when certain types of abnormal cells are produced. It can
occur in different parts of the body
? A wide variety of factors are involved in the development of cancer . Some
are related to family history, while others are related to lifestyle and diet.
? Avoiding smoking, eating a balanced diet with plenty of fruit and
vegetables and moderate amounts of red and processed meats, keeping
body weight within the healthy range for height and keeping alcohol
consumption to a moderate level, all help to reduce the risk of cancer .
What Is Cancer ?
The body is made up of small units called cells. New cells are constantly
produced to replace cells that have become worn out or damaged. New cells are
also made during growth, e.g . during infancy and childhood. Normally, the body
regulates the growth of new cells but occasionally ...
[282]
PERIOCULAR SKIN CANCER – Skin Tumors Around The Eye
[46,7 KB]
From [www.asoprs.org] Last viewed: 07.09.2006
UPDATE MARCH 2004
European Association of Urology
GUIDELINES
ON
TESTICULAR
CANCER
M.P. Laguna (Chairperson), O. Klepp, A. Horwich, F. Algaba,
C. Bokemeyer, G. Pizzocaro, G. Cohn-Cedemark, P. Albers
Page 2
TABLE OF CONTENTS
PAGE
1
BACKGROUND
4
1.1
Methods
4
2
PATHOLOGY AND NATURAL HISTORY
4
3
DIAGNOSIS
5
3.1
Clinical examination
5
3.2
Imaging of the Testis
5
3.3
Serum Tumor Markers at diagnostic
5
3.4
Inguinal exploration and orchiectomy
6
3.5
Organ sparing surgery
6
3.6
Pathological examination of the testis
6
3.7
Diagnosis of Carcinoma in situ (Tin)
6
3.8
Screening
7
4
STAGING
7
4.1
Diagnostic tools
7
4.2
Serum tumour markers. Postorchiectomy ...
[283]
Texas Cancer Plan 2005: A statewide blueprint for cancer ...
[1586,9 KB]
From [www.tcc.state.tx.us] Last viewed: 07.09.2006
3
2
Cellular Health Series:
Cancer
Matthias Rath, M.D.
First Edition, February 2001
Cellular Health Series - Cancer . Copyright 2001 by Matthias Rath, M.D. All rights
reserved. Published by MR Publishing, Inc., Santa Clara, CA 95054
No part of this book may be used or reproduced in any manner whatsoever without
written permission except in the case of brief quotations embodied in critical
articles or reviews. For information, address:
This book is not intended as a substitute for the medical advice of a physician.
The reader should regularly consult a physician in matters relating to his or her
health and particularly in respect to any symptoms that may require diagnosis or
medical attention. The authors and the publisher disclaim responsibility for any
adverse effects resulting directly or indirectly from the information contained in this
book.
...
[284]
Lung Cancer
[74,6 KB]
From [www.aghealth.org] Last viewed: 07.09.2006
NC OFFICE • BATTELLE • CENTERS FOR PUBLIC HEALTH RESEARCH & EVALUATION
100 CAPITOLA DR, SUITE 301 • DURHAM, NC 27713 • 1-800-4AG-STUDY
Lung Cancer
Spring 2005
Lung Cancer
Lung cancer is one of the most frequently
diagnosed cancers in the world and is the leading
cause of cancer death.
Are participants in the Agricultural
Health Study at increased risk for
lung cancer ?
Based on the current findings from the study,
participants are significantly less likely – over
50% less likely – than other people in North
Carolina and Iowa to be diagnosed with lung
cancer . This is very good news for the farm
population.
Why do farmers, overall, have less
lung cancer than the general
population?
There may be several reasons, but the main one is
that farmers and their spouses smoke less than
non-farmers. Overall, 14% of Agricultural ...
[285]
Incidence of Cancer
[85,2 KB]
From [www.aghealth.org] Last viewed: 07.09.2006
NC OFFICE • BATTELLE • CENTERS FOR PUBLIC HEALTH RESEARCH & EVALUATION
100 CAPITOLA DR, SUITE 301 • DURHAM, NC 27713 • 1-800-4AG-STUDY
Incidence of Cancer
Spring 2005
Cancer Incidence
From enrollment in the
study through 2001,
Agricultural Health Study
participants were less
likely to be diagnosed with
cancer than other North
Carolina and Iowa
residents.
Understanding the incidence of cancer and its
causes among farmers, their spouses, and
others who are licensed pesticide applicators
is an important goal of the Agricultural
Health Study.
The design of the study—following a large
number of healthy individuals into the future
in a long-term and comprehensive way—sets
the Agricultural Health Study apart from
other studies and allows scientists to study
the occurrence of cancer as the study
population ...
[286]
Prostate Cancer
[94,3 KB]
From [www.aghealth.org] Last viewed: 07.09.2006
NC OFFICE • BATTELLE • CENTERS FOR PUBLIC HEALTH RESEARCH & EVALUATION
100 CAPITOLA DR, SUITE 301 • DURHAM, NC 27713 • 1-800-4AG-STUDY
Prostate Cancer
Spring 2005
Prostate Cancer
Prostate cancer is one of the diseases of
particular interest to the Agricultural Health
Study because it is the most common cancer
among American men and because it has been
reported in other studies to be high among
farmers.
Does research in the Agricultural
Health Study indicate that pesticide
applicators are at increased risk for
prostate cancer ?
Research in the Agricultural Health Study shows
that the incidence of prostate cancer among
licensed restricted-use pesticide applicators is
slightly higher (14%) than it is for other men in
North Carolina and Iowa.
Risk factors observed in other studies—age and a
family history of prostate ...
[287]
Ontario Cancer Treatment Practice Guidelines Initiative
[160,0 KB]
From [www.cancercare.on.ca] Last viewed: 07.09.2006
Combined Modality Radiotherapy and Chemotherapy in the
Non-surgical Management of Localized Carcinoma of the Esophagus
Practice Guideline Report #2-12
Wong RKS, Malthaner RA, Zuraw L, Rumble RB, and members of Cancer Care Ontario’s Program
in Evidence-based Care’s Gastrointestinal Cancer Disease Site Group.
ORIGINAL GUIDELINE: April 17, 2002
MOST RECENT LITERATURE SEARCH: February 10, 2005
NEW EVIDENCE ADDED TO GUIDELINE REPORT: June 26, 2003
New evidence found by update searches since completion of the original guideline is consistent
with the original recommendations.
SUMMARY
Guideline Question
Does combined modality radiotherapy and chemotherapy improve survival compared with radiotherapy
alone in patients with localized carcinoma of the esophagus for whom a non-surgical approach is
used?
Target Population
These recommendations apply to adult patients ...
[288]
final cancer
[719,7 KB]
From [www.public-health.uiowa.edu] Last viewed: 07.09.2006
1
2005 C
A N C E R I N
I
OWA
R
E POR T
Prostate Cancer in Iowa
S
TAT E
H
E A L T H
R
E G I S T R Y O F
I
OW A
Page 2
2
I
n 2005, an estimated 6,500 Iowanswilldie from cancer , 15 times
the number caused byauto fatalities. Cancer issecond onlyto heart
disease asa cause ofdeath. These projectionsare based upon
mortalitydatathe State Health RegistryofIowareceivesfrom the
IowaDepartmentofPublicHealth. The Registryhasbeen recording
the occurrence ofcancer in Iowasince 1973, and isone offourteen
registriesnationwide providing datatothe NationalCancer Institute.
With 2005 Cancerin Iowa the Registrymakesa generalreportto the
publicon the statusofcancer. Thisreportwillfocuson:
•adescription ofthe Registryand itsgoals;
• cancer estimatesfor ...
[289]
Ontario Cancer Treatment Practice Guidelines Initiative
[585,9 KB]
From [www.cancercare.on.ca] Last viewed: 07.09.2006
Combined Modality Radiotherapy and Chemotherapy in the
Non-surgical Management of Localized Carcinoma of the Esophagus
Practice Guideline Report #2-12
Wong RKS, Malthaner RA, Zuraw L, Rumble RB, and members of Cancer Care Ontario’s Program
in Evidence-based Care’s Gastrointestinal Cancer Disease Site Group.
ORIGINAL GUIDELINE: April 17, 2002
MOST RECENT LITERATURE SEARCH: February 10, 2005
NEW EVIDENCE ADDED TO GUIDELINE REPORT: June 26, 2003
New evidence found by update searches since completion of the original guideline is consistent
with the original recommendations.
SUMMARY
Guideline Question
Does combined modality radiotherapy and chemotherapy improve survival compared with radiotherapy
alone in patients with localized carcinoma of the esophagus for whom a non-surgical approach is
used?
Target Population
These recommendations apply to adult patients ...
[290]
NAO Report (HC 343 2004-05) The NHS Cancer Plan: A Progress Report ...
[613,3 KB]
From [www.nao.org.uk] Last viewed: 07.09.2006
Evidence-based Series #2-15: Section 1
Oral Capecitabine (Xeloda ) in the First-line Treatment of Metastatic
A Clinical Practice Guideline
W Koc
intestinal Cancer Disease
ence-based Care.
the
Program in Evidence-based Care (PEBC), Cancer Care Ontario (CCO)
Developed by the Gastrointestinal Cancer Disease Site Group
11, 2005
ent of patients
ther thymidylate
st, and time-to-
ion
er, who have not
notherapy with
nts who are at a
erapy, adjuvant
diagnosed with
Recommendations
•
In appropriate patients, standard combination chemotherapy consists of infusional 5-
fluouracil plus leucovorin calcium with either irinotecan or oxaliplatin (refer to the Program in
Evidence-based Care’s Practice Guideline #2-16b: Use of Irinotecan (Camptosar®, CPT-11)
Combined with 5-fluorouracil and Leucovorin (5FU/LV) as First-line ...
[291]
Michigan Cancer Consortium
[55,7 KB]
From [www.michigancancer.org] Last viewed: 07.09.2006
Michigan Cancer Consortium Guidelines for the Early Detection of Colorectal Cancer
February 2, 2005
Recommendations for Colorectal Cancer Screening (Table 1)
Based on Guidelines of the American Cancer Society (2004), the U.S. Multisociety Task Force (2003),
and the U.S. Preventive Services Task Force (2002)
•
If patient reports rectal bleeding a diagnostic evaluation is recommended (See Table 3.)
•
Screening should continue regardless of age; however, discontinuing screening is reasonable in patients whose age or
comorbid conditions limit life expectancy.
Table 1
AVERAGE RISK
Risk Category
Recommendation
1
Age to Begin
Interval
All people ages 50 and over not in the
categories below
- Fecal occult blood test (FOBT) *
- Flexible sigmoidoscopy (FS)
- Flexible sigmoidoscopy plus FOBT
...
[292]
P5_TA(2003)0270 Breast cancer
[96,3 KB]
From [www.epgbc.org] Last viewed: 07.09.2006
P5_TA(2003)0270
Breast cancer
European Parliament resolution on breast cancer in the European Union (2002/2279(INI))
The European Parliament ,
–
having regard to Article 152 of the EC Treaty as amended by the Treaty of Nice,
–
having regard to Article 35 of the Charter of Fundamental Rights of the European Union
1,
–
having regard to its resolution of 9 March 1999 on the report from the Commission to the
Council, the European Parliament, the Economic and Social Committee and the
Committee of the Regions on the state of women’s health in the European Community
2,
–
having regard to its resolution of 13 February 2003 on the Commission communication
on Community and national measures in relation to breast implants
3
,
–
having regard to its resolution of 4 October 2001 on the patenting of BRCA1 and BRCA2
breast cancer genes ...
[293]
Ovarian Cancer
[185,1 KB]
From [www.wellbeingofwomen.org.uk] Last viewed: 07.09.2006
Ovarian Cancer
Page 2
WellBeing of Women
Funding Vital Health Research
WellBeing of Women is about life – helping enable it, sustain it and make it the
best quality.
Women are the motivating factor for us and our aim is for women everywhere
to be free of fear and suffering from reproductive problems.
Our determination to meet the health needs of women today is as strong as it
was in 1964 when the charity started.
WellBeing of Women is dedicated to the challenge of raising greater awareness
and securing more support and funds to invest in new medical research in three
key areas of reproductive health:
G
Gynaecological Cancers
G
Pregnancy and Birth
G
Quality of Life problems
If you would like to know more about WellBeing of Women , please contact us at:
WellBeing of Women
27 Sussex Place
...
[294]
Colorectal Cancer Facts & Figures
[595,9 KB]
From [www.cancer.org] Last viewed: 07.09.2006
Estimated New Cancer Cases and Deaths by Sex for All Sites, US, 2004 *
Estimated New Cases
Estimated Deaths
Both Sexes
Male
Female
Both Sexes
Male
Female
All sites
1,368,030
699,560
668,470
563,700
290,890
272,810
Oral cavity & pharynx
28,260
18,550
9,710
7,230
4,830
2,400
Tongue
7,320
4,860
2,460
1,700
1,100
600
Mouth
10,080
5,410
4,670
1,890
1,070
820
Pharynx
8,250
6,330
1,920
2,070
1,460
610
Other oral cavity
2,610
1,950
660
1,570
1,200
370
Digestive system
255,640
135,410
120,230
134,840
73,240
61,600
Esophagus
14,250
10,860
3,390
13,300
10,250
3,050
Stomach
22,710
13,640
9,070
11,780
6,900
4,880 ...
[295]
SCIENCE AND TECHNOLOGY COMMITTEE – Inquiry into access to ...
[7,7 KB]
From [www.wcrf.org] Last viewed: 07.09.2006
SCIENCE AND TECHNOLOGY COMMITTEE – Inquiry into access to scientific
publications
World Cancer Research Fund International
The World Cancer Research Fund global network comprises WCRF International and its
member organisations – national charities based in different countries (in the USA –
AICR; in the UK – WCRF UK; in the Netherlands – WCRF NL; in Germany – WCRF
DE; and in Hong Kong – WCRF HK). The WCRF global network has the unique role of
translating scientific data into global health recommendations. These health
recommendations not only inform the public on cancer prevention, but they also help to
set the agenda for future cancer research and national health policies.
Background
In 1997, WCRF (World Cancer Research Fund) and its affiliate in the USA, AICR
(American Institute for Cancer Research) jointly published the ground breaking report,
Food, Nutrition and the Prevention of Cancer ...
[296]
Cancer Care Ontario Practice Guidelines Initiative
[167,3 KB]
From [www.cancercare.on.ca] Last viewed: 07.09.2006
Postoperative Adjuvant Radiation Therapy in Stage II or IIIA
Completely Resected Non-Small Cell Lung Cancer
Practice Guideline Report #7-1-1
G. Okawara, Y.C. Ung, B.R. Markman, J.A. Mackay, W.K. Evans,
and members of the Lung Cancer Disease Site Group
ORIGINAL GUIDELINE: September 10, 2002
MOST RECENT LITERATURE SEARCH: January 2005
NEW EVIDENCE ADDED TO REPORT: February 2005
New evidence found by update searches since the completion of the original guideline is
consistent with the original recommendations.
This practice guideline report, together with a companion report on postoperative adjuvant
chemotherapy with or without radiotherapy in completely resected non-small cell lung cancer
(PG #7-1-2, currently under development), replaces:
Practice Guideline Report #7-1: Postoperative Adjuvant Chemotherapy and/or Radiation
Therapy in Stage II or IIIA Completely Resected ...
[297]
Cancer Facts & Figures for AfricanAmericans 2005-2006
[548,8 KB]
From [www.cancer.org] Last viewed: 07.09.2006
AMERICAN CANCER SOCIETY
INSTITUTIONAL RESEARCH GRANTS
POLICIES & INSTRUCTIONS
Effective January 2006
AMERICAN CANCER SOCIETY, INC.
Extramural Grants Department
1599 Clifton Road, N.E.
Atlanta, Georgia 30329-4251
Voice: (404) 329-7558
Fax: (404) 321-4669
Web site: http://www. cancer .org
Email: grants@ cancer .org
MISSION
The American Cancer Society is the nationwide, community-based, voluntary health
organization dedicated to eliminating cancer as a major health problem by preventing
cancer , saving lives and diminishing suffering from cancer through research, education,
advocacy, and service.
Page 2
General Policies - January 2006
2
AMERICAN CANCER SOCIETY EXTRAMURAL GRANTS
POLICIES
CONTENTS
1.
OVERVIEW OF THE EXTRAMURAL GRANTS PROGRAM OF THE AMERICAN
...
[298]
Cancer and the Environment: A Case for the Precautionary Principle ...
[480,3 KB]
From [www.hbcac.org] Last viewed: 07.09.2006
The New York State Breast Cancer Network
advocates for the adoption of the
Precautionary Principle in guiding public policy
and planning in New York State and urges
its incorporation into all relevant legislative,
administrative, and regulatory activities.
Let's face the alarming facts about cancer incidence rates
in New York State. Our state places third in total cancer
incidence rates for men and women and second in
breast cancer incidence rates in the US. Unfortunately,
cancer strikes children as well as adults. Incidence rates of
all childhood cancers have risen nearly 21% between 1975
and 1998, with genetic factors accounting for only one-fifth
of these cases. We cannot blame genetics for causing adult
cancers either; to give just one example, genetic mutation
accounts for only 5-10% of all breast cancer cases.
Research over the last two decades has revealed that
...
[299]
Age-Adjusted Cancer Death Rates, Females by Site, US, 1930-2001
[28,5 KB]
From [www.cancer.org] Last viewed: 07.09.2006
For more information call toll free: 1-800-ACS-2345
or on the Internet, http://www. cancer .org
National Home Office: American Cancer Society, Inc., 1599 Clifton Road NE, Atlanta, GA 30329-4251, (404) 320-3333
National Media Office: 1180 Avenue of the Americas, New York, NY 10036, (212) 382-2169
©1997, American Cancer Society, Inc.
97-300M-No. 5008.97
The American Cancer Society is the nationwide, community-based,
voluntary health organization dedicated to eliminating cancer
as a major health problem by preventing cancer , saving lives and
diminishing suffering from cancer , through research,
education, advocacy, and service.
Page 2
S
pecial S
ection:
RA
CIAL AND ETHNI
C P
A
T
TER
N
S
Estimated number of new cancer cases in 1997 by state, total: 1,382,400 (excluding Puerto ...
[300]
Cancer Facts & Figures
[1821,9 KB]
From [www.cancer.org] Last viewed: 07.09.2006
Breast Cancer
Facts & Figures 2001-2002
Page 2
Table of Contents
What is breast cancer ?
1
Who gets breast cancer ?
1
How has the occurrence of breast cancer changed over time?
3
What factors influence breast cancer survival?
5
What are the known risk factors for breast cancer ?
7
Can breast cancer be prevented?
9
How can breast cancer be detected early?
10
How is breast cancer treated?
11
What research is currently being done on breast cancer ?
14
What resources are available in your community?
15
What is the American Cancer Society doing about breast cancer ?
16
Sources of Statistics
17
References
18
Acknowledgments
The production of this report would not have been possible without the
efforts of: Cheryll Cardinez, MSPH, Vilma Cokkinides, PhD, ...